What is it about?
We evaluated the prevalence of serologic markers for HBV and the prevalence and incidence of serologic markers for HCV in blood donors and estimated residual risk of window‐phase infections for HCVin Brazil.
Featured Image
Why is it important?
Continuous monitoring of the prevalence, incidence and residual risk of hepatitis B and C among blood donors may help to improve blood safety by targeting recruitment to lower risk donors and driving policies to enhance more sensitive laboratory screening methods.
Perspectives
We found low rates of hepatitis B and C viral infection among blood donors in Brazil, probably due to improvement in blood donor screening and use of more rigorous confirmatory assays and definitions than employed in previous studies. I am cionfident that for public health, these findings support the impact of preventive measures, such as promoting HBV vaccine effectiveness.
Dr Cesar de Almeida-Neto
Faculty of Medicine, University of São Paulo
Read the Original
This page is a summary of: Prevalence of serologic markers for hepatitis B and C viruses in Brazilian blood donors and incidence and residual risk of transfusion transmission of hepatitis C virus, Transfusion, August 2012, Wiley,
DOI: 10.1111/j.1537-2995.2012.03840.x.
You can read the full text:
Contributors
The following have contributed to this page
